GAMIDA CELL
Live / Registered — Registered (as of 11 Jul 2023)
What this means for you
Registered since 11 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88606995
- Registration number
- 7108147
- Mark type
- Stylized text
- Filed
- 06 Sept 2019
- Published for opposition
- 03 Mar 2020
- Registered
- 11 Jul 2023
- Attorney of record
- Mark A. Jansen
Goods and services
- Class 005 — Pharmaceuticals: Cell therapy pharmaceutical preparations; pharmaceutical preparations in the field of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders
- Class 042 — Scientific and technological services: Research and development in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders
Owner
- GAMIDA CELL INC., NAPLES, FL, US
- GAMIDA CELL LTD., KIRYAT GAT, IL
- Gamida Cell Inc., Boston, MA, US
- Gamida Cell Inc., Boston, MA, US
- Gamida Cell Inc., Boston, MA, US
Prosecution history
- 09 Oct 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Oct 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Oct 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 10 Sept 2025 — WITHDRAWAL OF ATTORNEY GRANTED
- 10 Sept 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 21 May 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 27 Mar 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 11 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 08 Jun 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Jun 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 May 2023 — STATEMENT OF USE PROCESSING COMPLETE